Douglas Emmett diskutieren
Douglas Emmett
WKN: A0LCP8 / Symbol: DEI / Name: Douglas Emmett / Aktie / REITs / Mid Cap /
9,95 €
-1,49 %
Douglas Emmett, Inc. (NYSE: DEI) had its price target lowered by analysts at Raymond James from $17.00 to $16.00. They now have an "outperform" rating on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett, Inc. (NYSE: DEI) had its price target raised by analysts at Wells Fargo & Company from $15.00 to $17.00. They now have an "overweight" rating on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett, Inc. (NYSE: DEI) was upgraded by analysts at Wedbush from a "neutral" rating to an "outperform" rating. They now have a $21.00 price target on the stock, up previously from $19.00.
Ratings data for DEI provided by MarketBeat
Douglas Emmett, Inc. (NYSE: DEI) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $20.00 price target on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett, Inc. (NYSE: DEI) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $16.00. They now have an "overweight" rating on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett, Inc. (NYSE: DEI) had its price target lowered by analysts at Piper Sandler from $20.00 to $18.00. They now have an "overweight" rating on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett (NYSE:DEI) had its price target raised by analysts at Wells Fargo & Company from $16.00 to $20.00. They now have an "overweight" rating on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett (NYSE:DEI) had its price target raised by analysts at Piper Sandler from $18.00 to $19.00. They now have an "overweight" rating on the stock.
Ratings data for DEI provided by MarketBeat
Douglas Emmett (NYSE:DEI) had its price target lowered by analysts at Wells Fargo & Company from $20.00 to $15.00. They now have an "overweight" rating on the stock.
Ratings data for DEI provided by MarketBeat
Neueste Beiträge
Wells_Fargo___Compan in Johnson & Johnson diskutieren